'The Next Chunk of Gold:' New CRISPR Fight Brewing

STAT's special report on 'legacies and lucrative drug profits'

Graphic by The Ophthalmologist

Revolutionary gene therapies are the flavor of the day in many circles, including at California’s $12 billion stem cell and gene therapy program. The road seemed clear to create one-and-done cures for previously uncurable, horrible afflictions.

But obstacles have arisen involving the “revolution.” The respected STAT online b…